PDF) Polycythemia Vera and Essential Thrombocythemia Patients Exhibit Unique Serum Metabolic Profiles Compared to Healthy Individuals and Secondary Thrombocytosis Patients
Essential thrombocythemia treatment algorithm 2018 | Blood Cancer Journal
(PDF) Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018
Essential Thrombocytosis: Practice Essentials, Pathophysiology, Epidemiology
Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage | Modern Pathology
Platelet Dysfunction and Thrombosis in JAK2V617F-Mutated Primary Myelofibrotic Mice | Arteriosclerosis, Thrombosis, and Vascular Biology
JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia: A High Resolution SNP Array Study - ScienceDirect
Frontiers | Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
Anagrelide: A Clinically Effective cAMP Phosphodiesterase 3A Inhibitor with Molecular Glue Properties | ACS Medicinal Chemistry Letters